4.6 • 683 Ratings
🗓️ 17 April 2017
⏱️ 21 minutes
🧾️ Download transcript
Christopher Gibson. He’s the co-founder and CEO of Recursion Pharmaceuticals, a biotech company leveraging the latest automation, computation and biological tools to perform drug discovery at scale. Chris holds a BS in bioengineering, a BA in managerial studies, and a bioengineering PhD from the University of Utah.
Famous Five:
Time Stamped Show Notes:
3 Key Points:
Resources Mentioned:
Click on a timestamp to play from that location
0:00.0 | This is the top, where I interview entrepreneurs who are number one or number two in their industry in terms of revenue or customer base. |
0:09.4 | You'll learn how much revenue they're making, what their marketing funnel looks like, and how many customers they have. |
0:16.1 | I'm now at $20,000 per talk. |
0:18.3 | Five and six million. |
0:19.3 | He is hell bent on global domination. We just broke our $100,000 unit sold mark Five and six million. He is hell-bent on global domination. |
0:21.2 | We just broke our 100,000 unit sole mark. |
0:23.9 | And I'm your host, Nathan Latka. |
0:27.7 | Many of you who I've met in person have seen my unbelievable dashboards that I built. |
0:32.2 | You know, I'm an analytics-like crazy person. |
0:35.0 | I love the data. |
0:36.1 | And I love presenting the data and beautiful |
0:37.9 | dashboards that my team can use on their mobile devices, their phones, and TVs throughout |
0:42.5 | the office. Now the way I do this without having to hire a big development team is at |
0:47.4 | Nathanlaka.com forward slash analytics. It's using a company called Clipfolio and I'll tell |
0:52.5 | you more later on in the show how I use them. |
0:54.9 | It's Nathanlacka.com forward slash analytics. |
0:57.7 | Top tribe, you know I don't have a lot of time to waste. |
1:00.3 | That's why I use fresh books to send out invoices and make sure I'm collecting my money. |
1:05.8 | To get your free month, go to Nathan Latka.com forward slash fresh books and enter the top in the How Did You Hear |
1:12.2 | About Us section? Guys, coming up today, you're in for Treated. It's episode 632. You're going to learn |
1:16.9 | from the recursion CEO. It's an enzyme company, so health technology. They raised $23 million |
1:22.1 | launched in 2013. Now they have 40 people and they're about to release a new drug to the market. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Nathan Latka, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Nathan Latka and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.